10.35

0.81% -0.15

Replimune Group Inc (REPL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$10.49

Aprire:

$10.35

Volume 24 ore:

65,948

Relative Volume:

0.01

Capitalizzazione di mercato:

$811.50M

Reddito:

Utile/perdita netta:

$-209.96M

Rapporto P/E:

-3.2737

EPS:

-3.16

Flusso di cassa netto:

$-176.27M

1 W Prestazione:

+4.10%

1M Prestazione:

+21.33%

6M Prestazione:

+6.77%

1 anno Prestazione:

-20.23%

Intervallo 1D:

$10.27

$10.53

Intervallo di 1 settimana:

$9.35

$11.26

Portata 52W:

$2.68

$14.80

Replimune Group Inc Stock (REPL) Company Profile

Nome

Replimune Group Inc

Settore

Healthcare (1134)

Industria

Biotechnology (632)

Telefono

(781) 222-9600

Indirizzo

500 UNICORN PARK, WOBURN, MA

Dipendente

479

Cinguettio

@Replimune

Prossima data di guadagno

2025-02-11

Ultimi documenti SEC

REPL's Discussions on Twitter

Confronta REPL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
REPL Replimune Group Inc	10.35	826.01M	0	-209.96M	-176.27M	-3.16
VRTX Vertex Pharmaceuticals Inc	461.75	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	734.14	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	467.05	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	915.48	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.65	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Replimune Group Inc Stock (REPL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-03	Aggiornamento	BMO Capital Markets	Underperform → Market Perform
2025-10-27	Aggiornamento	H.C. Wainwright	Neutral → Buy
2025-10-20	Aggiornamento	JP Morgan	Underweight → Neutral
2025-10-20	Aggiornamento	Leerink Partners	Market Perform → Outperform
2025-10-20	Aggiornamento	Piper Sandler	Neutral → Overweight
2025-10-20	Aggiornamento	Wedbush	Neutral → Outperform
2025-09-19	Downgrade	JP Morgan	Neutral → Underweight
2025-07-30	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2025-07-23	Downgrade	BMO Capital Markets	Outperform → Underperform
2025-07-23	Downgrade	Barclays	Overweight → Equal Weight
2025-07-23	Downgrade	H.C. Wainwright	Buy → Neutral
2025-07-22	Downgrade	JP Morgan	Overweight → Neutral
2025-07-22	Downgrade	Leerink Partners	Outperform → Market Perform
2025-07-22	Downgrade	Piper Sandler	Overweight → Neutral
2025-07-22	Downgrade	Wedbush	Outperform → Neutral
2025-06-20	Iniziato	Cantor Fitzgerald	Overweight
2024-08-28	Iniziato	ROTH MKM	Buy
2023-04-17	Ripresa	Piper Sandler	Overweight
2021-11-19	Iniziato	Piper Sandler	Overweight
2021-10-15	Ripresa	BTIG Research	Buy
2020-11-17	Iniziato	BTIG Research	Buy
2020-11-02	Iniziato	Jefferies	Buy
2020-10-15	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-07-01	Downgrade	H.C. Wainwright	Buy → Neutral
2020-05-05	Iniziato	Barclays	Overweight
2019-09-04	Iniziato	ROTH Capital	Buy
2019-07-23	Iniziato	Chardan Capital Markets	Buy
2019-07-12	Aggiornamento	JP Morgan	Neutral → Overweight
2019-07-08	Iniziato	H.C. Wainwright	Buy
2019-04-25	Iniziato	Wedbush	Outperform
2019-01-23	Downgrade	JP Morgan	Overweight → Neutral
2018-08-14	Iniziato	JP Morgan	Overweight
2018-08-14	Iniziato	Leerink Partners	Outperform

Mostra tutto

Replimune Group Inc Borsa (REPL) Ultime notizie

07:50 AM

Saturn V Capital Management LP Takes $1.20 Million Position in Replimune Group, Inc. $REPL - MarketBeat

07:50 AM

Dec 01, 2025

Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) Investors - The National Law Review

Dec 01, 2025

Levi & Korsinsky Helps Retail Investors SueWallSt Over Alleged Fraud by Replimune Group, Inc. - The National Law Review

Dec 01, 2025

Nov 27, 2025

Will Replimune Group Inc. stock reach all time highs in 2025Oil Prices & Risk Managed Investment Strategies - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

How Replimune Group Inc. stock trades during market volatility2025 Geopolitical Influence & Short-Term High Return Ideas - BỘ NỘI VỤ

Nov 26, 2025

Nov 25, 2025

Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma DrugHagens Berman (PR Newswire) - Aktiellt

Nov 25, 2025

Nov 22, 2025

What Is Driving Replimune Stock’s 98% Surge Today? - MSN

Nov 22, 2025

Nov 21, 2025

Can One97 Communications Limited Deliver Consistent Free Cash FlowsVolume Spike Alerts & Swing Trade Smarter With Data Insights - earlytimes.in

Nov 21, 2025

Replimune Group Inc. stock volume spike explainedWeekly Stock Analysis & Short-Term Trading Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

How Replimune Group Inc. stock reacts to global recession fearsMarket Trend Review & Smart Investment Allocation Insights - newser.com

Nov 20, 2025

Will Replimune Group Inc. stock deliver shareholder valueQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - newser.com

Nov 20, 2025

Using AI based signals to follow Replimune Group Inc.Bond Market & Long Hold Capital Preservation Tips - newser.com

Nov 20, 2025

Nov 19, 2025

Trend analysis for Replimune Group Inc. this weekWeekly Market Outlook & Low Volatility Stock Suggestions - newser.com

Nov 19, 2025

Replimune Group Executives Sell Shares for Tax Obligations - TradingView

Nov 19, 2025

[Form 4] Replimune Group, Inc. Insider Trading Activity - Stock Titan

Nov 19, 2025

Why Replimune Group Inc. stock is a must watch in 2025July 2025 Levels & Weekly High Momentum Picks - newser.com

Nov 19, 2025

Smart tools for monitoring Replimune Group Inc.’s price actionWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com

Nov 19, 2025